Skip to main content
. 2023 Apr 27;15(5):1346. doi: 10.3390/pharmaceutics15051346

Figure 2.

Figure 2

Clinical trials limited to “immunotherapy Intratumoral/Cancer”. An approximate distribution by type of therapy is given. See text for detailed explanations and limitations.